metyrapone
metyrapone is a pharmaceutical drug with 11 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
2
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
1
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Metyrapone for Mild Autonomous Cortisol Secretion (MACS)
Effects of Metyrapone in Patients With Endogenous Cushing's Syndrome
Effects of the Addition of Metyrapone to Antidepressant Therapy in Depression With Dexamethasone Suppression Test Non-suppression.
Stress Biomarkers:Attaching Biological Meaning to Field Friendly Salivary Measures
To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormones.
Clinical Trials (11)
Metyrapone for Mild Autonomous Cortisol Secretion (MACS)
Effects of Metyrapone in Patients With Endogenous Cushing's Syndrome
Effects of the Addition of Metyrapone to Antidepressant Therapy in Depression With Dexamethasone Suppression Test Non-suppression.
Stress Biomarkers:Attaching Biological Meaning to Field Friendly Salivary Measures
To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormones.
Cocaine-Metyrapone Interaction Study - 1
Cortisol and Nutritional Sympathetic Responsiveness
Antiglucocorticoid Augmentation of antiDepressants in Depression
A Placebo-Controlled Study of a Combination of Metyrapone and Oxazepam in Cocaine Addiction
Metyrapone as Additive Treatment in Major Depression
Study of the Approximate Entropy of Adrenocorticotropic Hormone and Cortisol Secretion in Patients With Head Injury
All 11 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 11